Melioidosis

• Published in: Netherlands journal of medicine Vol. 54; no. 2; pp. 76 - 79
• Main Authors: Beeker, A, Van de Stadt, K.D, Bakker, K
• Format: Journal Article
• Language: English
• Published: Alphen aan den Rijn Elsevier B.V 01.02.1999; Van zuiden
• Subjects: Anti-Bacterial Agents; Bacterial diseases; Biological and medical sciences; Burkholderia pseudomallei - isolation & purification; Burkholdria pseudomallei; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Human bacterial diseases; Humans; Infectious diseases; Male; Medical sciences; Melioidosis; Melioidosis - diagnosis; Melioidosis - drug therapy; Melioidosis - microbiology; Middle Aged; Pseudomonas pseudomallei; Tropical bacterial diseases; Tropical medicine; Melioidosis; Pseudomonas pseudomallei; Burkholdria pseudomallei; Human; β-Lactams; Male; Malignant hemopathy; Non Hodgkin lymphoma; Infection; Case study; Penicillin derivatives; Symptomatology; Antibiotic; Chemotherapy; Cephalosporin derivatives; Association; Imported disease; Treatment; Lymphoproliferative syndrome; Amoxicillin; Bacteriosis; Bacteria; Burkholderia pseudomallei; Antibacterial agent; Ceftazidime
• ISSN: 0300-2977; 1872-9061
• DOI: 10.1016/S0300-2977(98)00129-6

Melioidosis is an infection with the gram-negative bacillus Burkholdria pseudomallei, previous known as Pseudomonas pseudomallei. We present a case report of a man with Non-Hodgkin's Lymphoma, who after visiting Indonesia presented himself with a urosepsis, with positive cultures to B. pseudomallei. Melioidosis is endemic in areas of southeast Asia and the northern part of Australia. Infection with the B. pseudomallei has a high mortality rate. Diagnosis can be made on the basis of cultures, the bacteria grow on standard media. Treatment should be based up on sensitivity studies. The optimum duration of therapy and choice of antibiotics remain to be determined. Due to the increase in travel, the infection will be seen more frequently in other parts of the world.